Related references
Note: Only part of the references are listed.Secreted frizzled-related protein 4 expression is positively associated with responsiveness to Cisplatin of ovarian cancer cell lines in vitro and with lower tumour grade in mucinous ovarian cancers
Uttara Saran et al.
BMC CELL BIOLOGY (2012)
TRIP12 and UBR5 Suppress Spreading of Chromatin Ubiquitylation at Damaged Chromosomes
Thorkell Gudjonsson et al.
CELL (2012)
Molecular mechanisms of cisplatin resistance
L. Galluzzi et al.
ONCOGENE (2012)
PDGF Upregulates Mcl-1 Through Activation of β-Catenin and HIF-1α-Dependent Signaling in Human Prostate Cancer Cells
Shareen Iqbal et al.
PLOS ONE (2012)
Therapeutic Targeting of PELP1 Prevents Ovarian Cancer Growth and Metastasis
Dimple Chakravarty et al.
CLINICAL CANCER RESEARCH (2011)
Epigenetic suppression of the TGF-beta pathway revealed by transcriptome profiling in ovarian cancer
Noriomi Matsumura et al.
GENOME RESEARCH (2011)
MicroRNA 376c enhances ovarian cancer cell survival by targeting activin receptor-like kinase 7: implications for chemoresistance
Gang Ye et al.
JOURNAL OF CELL SCIENCE (2011)
Identification of phosphorylation sites on the E3 ubiquitin ligase UBR5/EDD
Jennifer Rutherford Bethard et al.
JOURNAL OF PROTEOMICS (2011)
Silencing of p130Cas in Ovarian Carcinoma: A Novel Mechanism for Tumor Cell Death
Alpa M. Nick et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Role of Bcl-2 family proteins and caspases in the regulation of apoptosis
Mohammad Shamsul Ola et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2011)
The EDD E3 ubiquitin ligase ubiquitinates and up-regulates β-catenin
Avital Hay-Koren et al.
MOLECULAR BIOLOGY OF THE CELL (2011)
Caspase-3 triggers a TPCK-sensitive protease pathway leading to degradation of the BH3-only protein puma
Abbas Hadji et al.
APOPTOSIS (2010)
Mcl-1 is an important determinant of the apoptotic response to the BH3-mimetic molecule HA14-1 in cisplatin-resistant ovarian carcinoma cells
Karin Simonin et al.
MOLECULAR CANCER THERAPEUTICS (2009)
A Composite Intronic Element Directs Dynamic Binding of the Progesterone Receptor and GATA-2
Angeliki Magklara et al.
MOLECULAR ENDOCRINOLOGY (2009)
The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro
P. M. O'Brien et al.
BRITISH JOURNAL OF CANCER (2008)
Targeting Aurora kinase with MK-0457 inhibits ovarian cancer growth
Yvonne G. Lin et al.
CLINICAL CANCER RESEARCH (2008)
Effect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growth
William M. Merritt et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
The E3 ubiquitin ligase EDD regulates S-phase and G2/M DNA damage checkpoints
Marcia A. Munoz et al.
CELL CYCLE (2007)
Degradation of Mcl-1 by β-TrCP mediates glycogen synthase kinase 3-induced tumor suppression and chemosensitization
Qingqing Ding et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Glycogen synthase kinase 3 inhibition improves insulin-stimulated glucose metabolism but not hypertension in high-fat-fed C57BL/6J mice
R. Rao et al.
DIABETOLOGIA (2007)
EDD mediates DNA damage-induced activation of CHK2
Michelle J. Henderson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Intraperitoneal delivery of liposomal siRNA for therapy of advanced ovarian cancer
Charles N. Landen et al.
CANCER BIOLOGY & THERAPY (2006)
Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy
Jyotsnabaran Halder et al.
CLINICAL CANCER RESEARCH (2006)
Long-term treatment with novel glycogen synthase kinase-3 inhibitor improves glucose homeostasis in ob/ob mice: Molecular characterization in liver and muscle
O Kaidanovich-Beilin et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
EphA2 as a target for ovarian cancer therapy
CN Landen et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2005)
Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery
CN Landen et al.
CANCER RESEARCH (2005)
An evaluation of cytotoxicity of the taxane and platinum agents combination treatment in a panel of human ovarian carcinoma cell lines
JA Smith et al.
GYNECOLOGIC ONCOLOGY (2005)
Mobilizing the proteolytic machine: cell biological roles of proteasome activators and inhibitors
M Rechsteiner et al.
TRENDS IN CELL BIOLOGY (2005)
Somatic mutations and altered expression of the candidate tumor suppressors CSNK1ε, DLG1, and EDD/hHYD in mammary ductal carcinoma
TJ Fuja et al.
CANCER RESEARCH (2004)
The proteasome: a proteolytic nanomachine of cell regulation and waste disposal
DH Wolf et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2004)
EDD, the human orthologue of the hyperplastic discs tumour suppressor gene, is amplified and overexpressed in cancer
JL Clancy et al.
ONCOGENE (2003)
Regulation of apoptosis by Bcl-2 family proteins
A Burlacu
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2003)
Identification of novel ERK2 substrates through use of an engineered kinase and ATP analogs
ST Eblen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
EDD, the human hyperplastic discs protein, has a role in progesterone receptor coactivation and potential involvement in DNA damage response
MJ Henderson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Increased MCL-1 expression is associated with poor prognosis in ovarian carcinomas
K Shigemasa et al.
JAPANESE JOURNAL OF CANCER RESEARCH (2002)
First non-ATP competitive glycogen synthase kinase 3 β (GSK-3β) inhibitors:: Thiadiazolidinones (TDZD) as potential drugs for the treatment of Alzheimer's disease
A Martinez et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Differences in DNA binding properties between E2F1 and E2F4 specify repression of the Mcl-1 promoter
R Croxton et al.
ONCOGENE (2002)
Direct repression of the Mcl-1 promoter by E2F1
R Croxton et al.
ONCOGENE (2002)
Biochemical and biological functions of the N-terminal, noncatalytic domain of extracellular signal-regulated kinase 2
ST Eblen et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Molecular targets of lithium action
CJ Phiel et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2001)
Share Paper
